An amino-terminal domain of Mxi1 mediates anti-myc oncogenic activity and interacts with a homolog of the Yeast Transcriptional Repressor SIN3
1995 · Cell · 370 citations
https://doi.org/10.1016/0092-8674(95)90356-9
N
Nicole Schreiber‐Agus
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
65
Papers
5.9K
Citations
30
h-index
45
i10-index
Nicole Schreiber‐Agus is an academic researcher from Albert Einstein College of Medicine. The author has contributed to research in topics: Epigenetics and DNA Methylation & Cancer-related Molecular Pathways & Ubiquitin and proteasome pathways. The author has an h-index of 30, co-authored 56 publications.
ORCID: 0000-0002-6771-1080Papers by this author
worksRole of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth
1998 · Nature · 195 citations
https://doi.org/10.1038/31008
Gene-target recognition among members of the Myc superfamily and implications for oncogenesis
2000 · Nature Genetics · 137 citations
https://doi.org/10.1038/72761
Suppression of Myc, but not E1a, transformation activity by Max-associated proteins, Mad and Mxi1.
1994 · Proceedings of the National Academy of Sciences · 124 citations
https://doi.org/10.1073/pnas.91.12.5503
Mouse Sin3A interacts with and can functionally substitute for the amino-terminal repression of the Myc antagonist Mxi1.
1996 · PubMed · 38 citations
Mxi1-SRα: a novel Mxi1 isoform with enhanced transcriptional repression potential
2004 · Oncogene · 17 citations
https://doi.org/10.1038/sj.onc.1208107
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat